Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor α expression

被引:198
作者
Moschen, Alexander R. [1 ,2 ]
Molnar, Clemens [3 ]
Geiger, Sabine [1 ]
Graziadei, Ivo [2 ]
Ebenbichler, Christoph F. [3 ]
Weiss, Helmut [4 ]
Kaser, Susanne [3 ]
Kaser, Arthur [1 ,2 ]
Tilg, Herbert [1 ,2 ]
机构
[1] Med Univ Innsbruck, Christian Doppler Res Lab Gut Inflammat, A-6020 Innsbruck, Austria
[2] Med Univ Innsbruck, Dept Internal Med 2, A-6020 Innsbruck, Austria
[3] Med Univ Innsbruck, Dept Internal Med 1, A-6020 Innsbruck, Austria
[4] SJOG HOsp, Dept Surg, Salzburg, Austria
关键词
INSULIN-RESISTANCE; IN-VIVO; OBESE-PATIENTS; NONFAT CELLS; TISSUE; ADIPONECTIN; CYTOKINES; RELEASE; INFLAMMATION; STEATOSIS;
D O I
10.1136/gut.2010.214577
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Severe obesity is a chronic inflammatory disease where various cytokines/adipocytokines play a key role. Pro-inflammatory cytokines such as interleukin 6 (IL-6) and tumour necrosis factor-alpha (TNF alpha) are produced by human adipose tissue dependent on the degree of obesity. Mouse studies suggest a key role of adipose tissue-derived IL-6 in hepatic insulin resistance via modification of liver suppressor of cytokine signalling 3 (SOCS-3) expression. Design and methods We examined the effect of excessive weight loss on systemic levels, subcutaneous and visceral adipose tissue and liver expression of IL-6 and TNF alpha in 20 severely obese patients undergoing laparoscopic adjustable gastric banding (LAGB). Furthermore, we studied liver expression of SOCS3, an important regulator of insulin resistance, and fat tissue expression of the anti-inflammatory adipocytokine adiponectin and its receptors. Serum and tissue samples were collected before and 6 months after LAGB surgery. Results IL-6/TNF alpha mRNA expression before weight loss were similar in subcutaneous and visceral adipose tissue and much higher compared to hepatic expression. Subcutaneous adipose tissue mRNA expression of both pro-inflammatory cytokines, but especially of IL-6 decreased dramatically after extensive weight loss whereas expression of adiponectin and its receptors increased. Weight loss also led to a significant reduction in liver IL-6 expression, whereas liver TNF alpha mRNA expression did not change. IL-6 and C-reactive protein serum levels decreased after weight loss whereas TNF alpha serum levels were below the detection limit before and after surgery. These effects were paralleled by reduced hepatic SOCS3 expression and improved insulin resistance 6 months after LAGB surgery. Conclusion Expression of IL-6 and TNF alpha mRNA is more pronounced in adipose compared to liver tissue in patients with severe obesity. Our results highlight excessive weight loss as a successful anti-inflammatory strategy.
引用
收藏
页码:1259 / 1264
页数:6
相关论文
共 50 条
  • [31] Loss of fat-free mass over four years in adult cystic fibrosis is associated with high serum interleukin-6 levels but not tumour necrosis factor-alpha
    King, Susannah J.
    Nyulasi, Ibolya B.
    Bailey, Michael
    Kotsimbos, Tom
    Wilson, John W.
    CLINICAL NUTRITION, 2014, 33 (01) : 150 - 155
  • [32] Anti-inflammatory effects of tumour necrosis factor (TNF)-α are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-β-treated antigen-presenting cells
    Masli, Sharmila
    Turpie, Bruce
    IMMUNOLOGY, 2009, 127 (01) : 62 - 72
  • [33] ABHD6 suppression promotes anti-inflammatory polarization of adipose tissue macrophages via 2-monoacylglycerol/PPAR signaling in obese mice
    Pourshari, P.
    Schmitt, C.
    Chenier, I.
    Leung, Y. H.
    Oppong, A. K.
    Bai, Y.
    Klein, L. -L.
    Al-Mass, A.
    Lussier, R.
    Abu-Farha, M.
    Abubaker, J.
    Al-Mulla, F.
    Peyot, M. -L.
    Madiraju, S. R. M.
    Prentki, M.
    MOLECULAR METABOLISM, 2023, 78
  • [34] Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-α, interleukin-6 and -8 in patients with ulcerative colitis
    Faghfoori, Zeinab
    Navai, Lida
    Shakerhosseini, Rahebeh
    Somi, Mohammad Hossein
    Nikniaz, Zeinab
    Norouzi, Mohammad Fahmideh
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 233 - 237
  • [35] Characterization of anti-inflammatory responses of norepinephrine in hepatitis induced by LPS: Effects on expression of IL-6, TNF-α and iNOS in liver of mice
    Abrehdari, Z.
    Pirestani, M.
    Allahdini, P.
    Safarpour, E.
    NEUROCHEMICAL JOURNAL, 2014, 8 (03) : 193 - 198
  • [36] Anti-Inflammatory Protein Tumor Necrosis Factor-α-Stimulated Protein 6 (TSG-6) Promotes Early Gingival Wound Healing: An In Vivo Study
    Beltran, Stacy R.
    Svoboda, Kathy K. H.
    Kerns, David G.
    Sheth, Akash
    Prockop, Darwin J.
    JOURNAL OF PERIODONTOLOGY, 2015, 86 (01) : 62 - 71
  • [37] Regulatory effects of tumor necrosis factor-alpha and interleukin-6 on HAMP expression in iron loaded rat hepatocytes
    Dzikaite, V
    Holmström, P
    Stål, P
    Eckes, K
    Hagen, K
    Eggertsen, G
    Gåfvels, M
    Melefors, Ö
    Hultcrantz, R
    JOURNAL OF HEPATOLOGY, 2006, 44 (03) : 544 - 551
  • [38] Anti-inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor-kappa B
    Huang, Longfei
    Guan, Teng
    Qian, Yisong
    Huang, Menghao
    Tang, Xuzhen
    Li, Yunman
    Sun, Hongbin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 672 (1-3) : 169 - 174
  • [39] Role of interleukin 6 signaling pathway in the anti-inflammatory effects of statins on coronary artery disease: Evidence from Mendelian randomization analysis
    Yazdanpanah, Mojgan
    Yazdanpanah, Nahid
    Chardoli, Mojtaba
    Dehghan, Abbas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 406
  • [40] Serum levels of tumour necrosis factor-α and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate -: preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy
    Grim-Stieger, M.
    Keilani, M.
    Mader, R. M.
    Marosi, C.
    Schmidinger, M.
    Zielinski, C.
    Fialka-Moser, V.
    Crevenna, R.
    EUROPEAN JOURNAL OF CANCER CARE, 2008, 17 (05) : 454 - 462